
Cardiovascular Systems CSII
Quarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Interest Expense 2011-2026 | CSII
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.63 M | 1.74 M | 1.97 M | 1.68 M | 1.72 M | 500 K | - | 23 K | 1.03 M | 1.34 M | 1.36 M | 1.42 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.97 M | 23 K | 1.31 M |
Quarterly Interest Expense Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 404 K | 406 K | 810 K | 408 K | 409 K | 410 K | 819 K | 412 K | 412 K | 499 K | 412 K | 501 K | 500 K | 472 K | 500 K | 472 K | 422 K | 424 K | 422 K | 424 K | 430 K | 432 K | 430 K | 432 K | 46 K | - | - | - | - | - | - | 1 K | 6 K | 16 K | 22 K | 103 K | 564 K | 281 K | 564 K | 281 K | 345 K | 370 K | 345 K | 370 K | 279 K | 344 K | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 819 K | 1 K | 380 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 14.04 | 0.79 % | $ 2.11 B | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 15.16 | 4.19 % | $ 410 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 6.62 | 3.6 % | $ 475 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 31.22 | -3.94 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.59 | 2.68 % | $ 171 M | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.42 | -3.39 % | $ 118 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Electromed
ELMD
|
78 K | $ 23.92 | 3.33 % | $ 202 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 269.65 | 0.29 % | $ 7.61 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.89 | 0.3 % | $ 5.94 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 73.48 | -2.22 % | $ 109 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 100.5 | 1.42 % | $ 1.27 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 45.98 | -0.17 % | $ 1.43 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 70.29 | 1.8 % | $ 3.83 B | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 1.63 | 7.95 % | $ 63.8 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 96.65 | -0.1 % | $ 124 B | ||
|
MiMedx Group
MDXG
|
-558 K | $ 5.28 | -1.31 % | $ 780 M | ||
|
Delcath Systems
DCTH
|
-30 K | $ 10.21 | 2.61 % | $ 291 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
21.1 K | $ 0.75 | 16.11 % | $ 5.29 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
-15.3 M | $ 78.29 | -1.73 % | $ 2.2 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 248.12 | 1.17 % | $ 17.5 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 7.4 | 3.5 % | $ 180 M | ||
|
Quanterix Corporation
QTRX
|
2.25 M | $ 6.29 | 10.35 % | $ 236 M |